The Liver Lounge
The Liver Foundation
A podcast initiative by The Liver Foundation where we discuss the latest updates in hepatology with the world’s leading experts. In each episode, we bring you the latest updates, breakthroughs, and insights on a myriad of topics, from the intricacies of steatotic liver disease to the complexities of residency matching. Whether you’re a medical professional, researcher, or simply intrigued by the liver’s vital role in our health, this podcast is your go-to source for staying informed and engaged with cutting-edge developments in hepatology.
Categories: Health
Listen to the last episode:
Welcome to our latest episode featuring Professor Emmanouil Tsochatzis, a distinguished Professor of Hepatology and Honorary Consultant at the UCL Institute for Liver and Digestive Health in the Royal Free Hospital. Today, we embark on an exploration of the profound impact of Metabolic-Associated Steatohepatitis (MASH) on individuals grappling with type 2 diabetes mellitus. Prepare to delve into the intricate details of this pressing issue as Professor Tsochatzis sheds light on the burden of MASH, unraveling its complexities and implications for those affected. Moreover, we'll uncover his latest groundbreaking research, recently published in The Lancet, advocating for the implementation of liver health checks in people with type 2 diabetes. Join us for an enlightening discussion at the forefront of liver health and metabolic diseases, as we navigate the terrain of MASH and its intersection with diabetes. Stay tuned for insights that could redefine our approach to managing these conditions.
Previous episodes
-
31 - 31: Burden of MASH in patients with Type 2 Diabetes MellitusFri, 05 Apr 2024 - 0h
-
30 - 30: Hepatitis B Care in AfricaFri, 22 Mar 2024 - 0h
-
29 - 29: Molecular Mechanisms underlying Alcohol Abstinence and Relapse in ALDFri, 08 Mar 2024 - 0h
-
28 - 28: Gut Microbiome in Liver CancerFri, 23 Feb 2024 - 0h
-
27 - 27: ACG Clinical Guideline for ALDThu, 15 Feb 2024 - 0h
-
26 - 26: Elafibranor in Primary Biliary CholangitisFri, 09 Feb 2024 - 0h
-
25 - 25: Decoding HCC in Autoimmune HepatitisFri, 02 Feb 2024 - 0h
-
24 - 24: Decoding Immunotherapy-Related Liver Injury in Hepatocellular CarcinomaFri, 26 Jan 2024 - 0h
-
23 - 23: Navigating the Landscape of Living Liver Donor Psychosocial Evaluations in the U.S.Fri, 19 Jan 2024 - 0h
-
22 - 22: Alpha-1 Antitrypsin Deficiency-Associated Liver DiseaseFri, 12 Jan 2024 - 0h
-
21 - 21: Confronting Obesity and Steatotic Liver Disease ChallengesThu, 04 Jan 2024 - 0h
-
20 - 20: Blood-based Biomarkers for HCC SurveillanceFri, 15 Dec 2023 - 0h
-
19 - 19: Latest Advancements in Liver TransplantationFri, 08 Dec 2023 - 0h
-
18 - 18: A Nurse Practitioner’s Insights on Alcohol-Associated Liver DiseaseFri, 01 Dec 2023 - 0h
-
17 - 17: Prevalence, Mortality, and Biomarkers of Acute Kidney Injury in Severe Alcohol-Related HepatitisFri, 24 Nov 2023 - 0h
-
16 - 16: The Sobering Truth - The Rising Costs of Alcohol-Associated Liver Disease in the United StatesFri, 17 Nov 2023 - 0h
-
15 - 15: How Accurate is Diagnostic Imaging in Compensated Cirrhosis?Mon, 06 Nov 2023 - 0h
-
14 - 14: Fueling Your Health - Diet’s Role in Taming Non-Alcoholic Fatty Liver DiseaseFri, 03 Nov 2023 - 0h
-
13 - 13: Global Disparities in Cirrhosis Mortality and Liver Transplantation - CLEARED ConsortiumFri, 27 Oct 2023 - 0h
-
12 - 12: Global Public Health Agenda for Steatotic Liver Disease - Expert Insights into MASLDFri, 20 Oct 2023 - 0h
-
11 - 11: Cost Barriers of Rifaxamin in Hepatic Encephalopathy TreatmentFri, 13 Oct 2023 - 0h
-
10 - 10: Mastering Cirrhosis Management - BSG Best Practice GuidanceFri, 06 Oct 2023 - 0h
-
9 - 09: Liver Transplantation in NASH CirrhosisFri, 29 Sep 2023 - 0h
-
8 - 08: Medications and Liver Health in Alcohol Use DisorderFri, 22 Sep 2023 - 0h
-
7 - 07: Breaking Down the Silent Threat of Nash-Related CirrhosisFri, 15 Sep 2023 - 0h
-
6 - 06: Liver Disease and Healthcare in VeteransFri, 08 Sep 2023 - 0h
-
5 - 05: Bariatric Endoscopy’s Impact on Chronic Liver DiseaseFri, 01 Sep 2023 - 0h
-
4 - 04: Confronting Alcohol Withdrawal in Alcohol-associated HepatitisFri, 25 Aug 2023 - 0h
-
3 - 03: Fatty Liver to Deadly Tumor: Surveillance of NAFLD-HCCFri, 18 Aug 2023 - 0h
-
2 - 02: Getting #Match for GI FellowshipFri, 11 Aug 2023 - 0h
-
1 - 01: MASLD - The New NAFLD Nomenclature?Sun, 06 Aug 2023 - 0h
